We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Olympus

Manufactures optical and digital equipment for the healthcare and consumer electronics sectors, including endoscopy a... read more Featured Products: More products

Download Mobile App




Fluorescent Reagents Evaluated for Vulvovaginal Candidiasis Diagnosis

By LabMedica International staff writers
Posted on 29 Jul 2021
Vulvovaginal candidiasis (VVC) is a common vaginitis in females, which is estimated to be the second most common cause of vaginitis after bacterial vaginosis. More...
Vulvovaginal candidiasis affects around 70%–75% of all women during their childbearing age, and is considered to be an important public health problem.

The morbidity associated with VVC makes it a major cause of causing pain, great discomfort, mental distress, anxiety, altered self-esteem, impairing work performance and interfering with sexual and affective relations. The signs of VVC are typically characterized white clumpy discharge. The commonly used diagnostic method is 10% potassium hydroxide (KOH) smear microscopy.

Clinical Laboratorians at the Capital Medical University (Beijing, China) and their associates recruited patients according to the symptoms and the signs included vaginal discharge, irritation, itching, and/or odor, and who were suspected of having VVC, from October 2018 to February 2019. A total of 110 specimens were obtained with suspected VVC, aged 19–60 years, with an average age of 30.99 ± 7.77 years.

The team used different methods to detect VVC: fungal culture, fluorescent microscopy observation with Calcofluor White (CFW) and fluorescent brightener 85 (FB 85). The swabs were smeared on two separate slides, one with a drop of CFW, the other with a drop of 0.1% FB 85. The secretions gathered from the dilator were smeared on a third slide and examined using KOH under a light microscopy by adding a drop of 10% KOH to the slide. Microscopic observations were conducted using an Olympus CX23 LEDRFSIC microscopy (Olympus Co., Ltd, Tokyo, Japan) using either the 340–380 nm ultraviolet light mode or the visible light mode.

The scientists reported that in the 110 specimens, 75/110 (68.2%) were positive by the KOH method, 71/110 (64.5%) were positive by the CFW fluorescent method, 68/110 (61.8%) were positive by the FB 85 fluorescent method, and 77/110 (77%) were positive by the fungal culture method. In the 110 specimens, the specificity of the three methods was 100%. The sensitivity, and accuracy of CFW were the highest, followed by KOH method and FB 85 was the lowest.

For the VVC caused by Candida glabrata, yeast form was always observed, which is very clear with the CFW method and the FB 85 method, but was not easily found by light microscopy. The team observed a fade time of two fluorescent reagents under daylight in the room environment and due to the crystals and the faint fluorescence, it was harder to distinguish the fungi from the 24 hours specimen than the fresh specimen.

The authors concluded that they could find pathogenic fungi more quickly with fluorescent method in diagnosis of VVC. Both CFW and FB 85 were good reagents. FB 85 is a new fluorescent reagent for the diagnosis of VVC and other fungal affection diseases and has potential value for clinical applications. The study was published on July 12, 2021 in the Journal of Clinical Laboratory Analysis.

Related Links:
Capital Medical University
Olympus Co., Ltd



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.